Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin A Zivin

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Stroke|June 5, 2004
SLOW-MAGJustin A Zivin
Stroke|July 19, 2008
Identifying low-quality preclinical studiesJustin A Zivin
Stroke|January 31, 2007
Clinical trials of neuroprotective therapiesJustin A Zivin
Annals of Neurology|August 15, 2009
Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA)Justin A Zivin
Stroke|March 26, 2005
Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: conJustin A Zivin
American Journal of Therapeutics|May 23, 2007
Emerging therapies for acute ischemic strokeJustin A Sattin, Justin A Zivin
Annals of Emergency Medicine|March 4, 2008
Empirical characteristics of litigation involving tissue plasminogen activator and ischemic strokeBryan A Liang, Justin A Zivin
Experimental Neurology|October 15, 2008
The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activatorPaul A Lapchak, Justin A Zivin
Handbook of Clinical Neurology|September 17, 2008
Methodology of acute trials in strokeThomas M Hemmen, Justin A Zivin
Stroke|July 12, 2003
Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activatorPaul A Lapchak, Justin A Zivin
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Stroke|June 5, 2004
SLOW-MAGJustin A Zivin
Stroke|July 19, 2008
Identifying low-quality preclinical studiesJustin A Zivin
Stroke|January 31, 2007
Clinical trials of neuroprotective therapiesJustin A Zivin
Annals of Neurology|August 15, 2009
Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA)Justin A Zivin
Stroke|March 26, 2005
Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: conJustin A Zivin
American Journal of Therapeutics|May 23, 2007
Emerging therapies for acute ischemic strokeJustin A Sattin, Justin A Zivin
Annals of Emergency Medicine|March 4, 2008
Empirical characteristics of litigation involving tissue plasminogen activator and ischemic strokeBryan A Liang, Justin A Zivin
Experimental Neurology|October 15, 2008
The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: a combination therapy study with tissue plasminogen activatorPaul A Lapchak, Justin A Zivin
Handbook of Clinical Neurology|September 17, 2008
Methodology of acute trials in strokeThomas M Hemmen, Justin A Zivin
Stroke|July 12, 2003
Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activatorPaul A Lapchak, Justin A Zivin
Pageof 6